
Weight loss jabs could halve the risk of obesity-related cancers, a landmark study has found.
Injections such as Ozempic, Mounjaro and WeGovy could have a preventative effect on a number of cancers, according to new research carried out.

Weight loss jabs could halve the risk of obesity-related cancers, a landmark study has found.
Injections such as Ozempic, Mounjaro and WeGovy could have a preventative effect on a number of cancers, according to new research carried out.